Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Browse archives for older articles from 2016, 2015, 2014 (all articles may be found in search)

Did you know how medwireNews writes our articles?


Date Title Topic
16 Nov 2018 ‘Alarming’ Data Reported For Minimally Invasive Surgical Approach In Early Cervical Cancer Cervical Cancer - Surgical Oncology
15 Nov 2018 Cardiovascular irAE Risk Highlighted With Immune Checkpoint Inhibitor Use Immunotherapy - Complications/Toxicities of Treatment
14 Nov 2018 Tumour Stage May Aid Treatment Decision For Advanced Tubo-Ovarian Carcinoma Patients Gynaecological Malignancies - Ovarian Cancer - Anticancer agents - Surgical Oncology
13 Nov 2018 Omitting Anthracyclines May Be ‘Preferred’ Approach For Early HER2-Positive Breast cancer Breast Cancer - Personalised/Precision Medicine - Anticancer agents
12 Nov 2018 Elotuzumab Addition Improves Relapsed, Refractory Multiple Myeloma PFS Plasma Cell Dyscrasias - Anticancer agents
09 Nov 2018 Predictive Markers Of Late HCC Recurrence Uncovered Hepatobiliary Cancers
08 Nov 2018 Phase II Lorlatinib Results Confirm Activity Against Advanced ALK-Positive NSCLC Non-Small Cell Lung Cancer - Personalised/Precision Medicine - Anticancer agents
07 Nov 2018 First-Line Sequential Chemotherapy Not Equal To Combination Strategy For Metastatic CRC Colon and Rectal Cancer - Anticancer agents
06 Nov 2018 Durvalumab Alone, Alongside Tremelimumab Feasible For Advanced PD-L1-Negative HNSCC Immunotherapy - Head and Neck Cancers
05 Nov 2018 Primary GIST Recurrence Halted During 5-Year Imatinib Therapy Anticancer agents - Personalised/Precision Medicine - GIST
02 Nov 2018 First-Line Pembrolizumab Plus Platinum-Based Chemotherapy ‘Standard Of Care’ For Advanced HNSCC Anticancer agents - Immunotherapy - Head and Neck Cancers
31 Oct 2018 ALESIA Favours First-Line Alectinib For Asian ALK-Positive Advanced NSCLC Patients Anticancer agents - Non-Small Cell Lung Cancer - Personalised/Precision Medicine
30 Oct 2018 Cisplatin Superior To Cetuximab For Low-Risk, HPV-Positive Oropharyngeal Cancer Anticancer agents - Head and Neck Cancers - Radiation Oncology
29 Oct 2018 PALOMA-3 OS Results Add Support For Palbociclib Use In Advanced Breast Cancer Anticancer agents - Breast Cancer
26 Oct 2018 Avelumab Plus Axitinib ‘New First-Line Standard Of Care’ For Advanced RCC Anticancer agents - Immunotherapy